Patents by Inventor James L. McGaugh

James L. McGaugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drugs to improve synaptic transmission
    Patent number: 7081474
    Abstract: Peripherally administered Brefeldin A and its analogs and derivatives are used to enhance learning and reverse memory dysfunction through induced long term potentiation in hippocampal issues.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: July 25, 2006
    Assignee: The Regents of the University of California
    Inventors: Katumi Sumikawa, Ken-Ichi Ito, James L. McGaugh
  • Drugs to improve synaptic transmission
    Publication number: 20040242553
    Abstract: Peripherally administered Brefeldin A and its analogs and derivatives are used to enhance learning and reverse memory dysfunction through induced long term potentiation in hippocampal issues.
    Type: Application
    Filed: March 22, 2004
    Publication date: December 2, 2004
    Applicant: The Regents of the University of California a Oakland, California corporation
    Inventors: Katumi Sumikawa, Ken-Ichi Ito, James L. McGaugh
  • Drugs to improve synaptic transmission
    Patent number: 6710073
    Abstract: Peripherally administered analogs and derivatives of Brefeldin A are used to enhance learning and reverse memory dysfunction through induced long term potentiation in hippocampal tissues.
    Type: Grant
    Filed: December 2, 1996
    Date of Patent: March 23, 2004
    Assignee: The Regents of the University of California
    Inventors: Katumi Sumikawa, Ken-Ichi Ito, James L. McGaugh